| Title | Author(s) | Year | View Count |
 | Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus | Ba, L; Yi, CE; Zhang, L; Ho, DD; Chen, Z | 2007 | 179 |
| Natural mutations in the receptor binding domain of spike glycoprotein determine the reactivity of cross-neutralization between palm civet coronavirus and severe acute respiratory syndrome coronavirus | Liu, L; Fang, Q; Deng, F; Wang, H; Yi, CE; Ba, L; Yu, W; Lin, RD; Li, T; Hu, Z; Ho, DD; Zhang, L; Chen, Z | 2007 | 46 |
| Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals | Zhang, L; Zhang, F; Yu, W; He, T; Yu, J; Yi, CE; Ba, L; Li, W; Farzan, M; Chen, Z; Yuen, KY; Ho, D | 2006 | 64 |
 | Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region | Chen, Z; Zhang, L; Qin, C; Ba, L; Yi, CE; Zhang, F; Wei, Q; He, T; Yu, W; Yu, J; Gao, H; Tu, X; Gettie, A; Farzan, M; Yuen, KY; Ho, DD | 2005 | 266 |
| Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain | Yi, CE; Ba, L; Zhang, L; Ho, DD; Chen, Z | 2005 | 44 |
|
